<DOC>
	<DOC>NCT01143974</DOC>
	<brief_summary>For patients resistant to enthrycycline and taxanes, there is no standard regimen. Pemetrexed alone had certain efficacy in treatment of advance breast cancer. Platin was also a effective drug for advanced breast cancer. The combination of these two drug may have a synergy with each other in treatment of advanced breast cancer.</brief_summary>
	<brief_title>Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer</brief_title>
	<detailed_description>combination of pemetrexed and cisplatin to treat advanced breast cancer. Previous regimen no more than 3 which including enthrycycline and taxanes(paclitaxel and/or docetaxel)</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>1870 years old Resistant to enthracycle and taxanes Has measurable disease Has more than 3 previous chemotherapy regimens</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>progress free survival</keyword>
	<keyword>response rate</keyword>
	<keyword>safety</keyword>
</DOC>